Treatment Strategy for Chronic Obstructive Parotitis Related to Diabetes


Objectives: The aim of this study was to describe our experience in treating chronic obstructive parotitis related to diabetes.
Methods: Twelve patients with chronic obstructive parotitis (COP) related to diabetes were selected for the study. A sialendoscope was introduced from the orifice to investigate the ductal wall and lumen. During the operation, chymotrypsin and gentamicin were injected. All patients were followed up for 6 months. Preoperative and postoperative visual analog scale (VAS) evaluations and salivary gland scintigraphy (SGS) examinations were applied to evaluate the therapeutic effect; differences were considered statistically significant at P < 0.05.
Results: A sialendoscope was successfully used under local anaesthesia in all members of the cohort. As shown by the endoscope, mucus plugs were the most common feature. Some adhered tightly to the ductal wall. We also found ductal congestion in some cases. The postoperative VAS scores and SGS counts were both significantly lower than the preoperative values (P < 0.05).
Conclusion: Chymotrypsin administration during interventional sialendoscopy is significantly effective in the treatment of diabetes-related COP.


Diabetes, COP, Sialendoscope, VAS, effect

Get access to the full version of this article.

Article Info

Article Type
Research Article
Publication history
Received: Wed 30, Mar 2022
Accepted: Fri 15, Apr 2022
Published: Tue 03, May 2022
© 2023 Lei Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JSO.2022.02.01

Author Info

Corresponding Author
Lei Xue
Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, PR China

Figures & Tables

Get access to the full version of this article.


1.     Wu CB, Xi H, Zhou Q, Zhang LM (2015) Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis. J Oral Maxillofac Surg 73: 475-481. [Crossref]

2.     Guo YF, Sun NN, Wu CB, Xue L, Zhou Q (2017) Sialendoscopy-assisted treatment for chronic obstructive parotitis related to Sjogren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 123: 305-309. [Crossref]

3.     Cai R, Wu M, Xing Y (2019) Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant. Ther Clin Risk Manag 15: 497-503. [Crossref]

4.     Liu L, Huang Y, Fang C, Zhang H, Yang J et al. (2018) Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model. PLos One 13: e0195411. [Crossref]

5.     Löe H (1993) Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1: 329-334. [Crossref]

6.     Negrato CA, Tarzia O (2010) Buccal alterations in diabetes mellitus. Diabetol Metab Syndr 2: 3. [Crossref]

7.     Takeuchi K, Furuta M, Takeshita T, Shibata Y, Shimazaki Y et al. (2015) Risk factors for reduced salivary flow rate in a Japanese population: the Hisayama Study. Biomed Res Int 2015: 381821. [Crossref]

8.     Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13: 227-236. [Crossref]

9.     López-Pintor RM, Casañas E, González-Serrano J, Serrano J, Ramírez L et al. (2016) Xerostomia, Hyposalivation, and Salivary Flow in Diabetes Patients. J Diabetes Res 2016: 4372852. [Crossref]

10.  Lima DLF, Carneiro SDRM, de Sousa Barbosa FT, de Lima Saintrain MV, Moizan JAH et al. (2017) Salivary flow and xerostomia in older patients with type 2 diabetes mellitus. PLoS One 8: e0180891. [Crossref]

11.  Abdullayev R, Saral FC, Kucukebe OB, Sayiner HS, Bayraktar C et al. (2016) [Bilateral parotitis in a patient under continuous positive airway pressure treatment]. Rev Bras Anestesiol 66: 661-663. [Crossref]

12.  Wu CB, Xue L, Zhang B et al. (2015) Sialendoscopy-Assisted Treatment for Chronic Obstructive Parotitis—Our Treatment Strategy with 31 Patients. J Oral Maxillofac Surg 8: 1524-1531. [Crossref]

13.  Plonowska KA, Gurman ZR, Humphrey A, Chang JL, Ryan WR (2019) One-year outcomes of sialendoscopic-assisted salivary duct surgery for sialadenitis without sialolithiasis. Laryngoscope 129: 890-896. [Crossref]

14.  Sun HJ, Xiao JQ, Qiao QH, Bao X, Wu CB et al. (2017) Chymotrypsin with sialendoscopy-assisted surgery for the treatment of chronic obstructive parotitis. Int J Oral Maxillofac Surg 46: 877-882. [Crossref]

15.  Kaldeway HP, Borg EJT, van de Garde EMW, Habraken JBA, van Buul MMC (2019) Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjögren's syndrome. Nucl Med Commun 40: 343-348. [Crossref]

16.  Markusse HM, Pillay M, Breedveld FC (1993) The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjögren's syndrome. Br J Rheumatol 32: 231-235. [Crossref]

17. Wu CB, Xi H, Zhou Q, Zhang LM (2015) The diagnostic value of technetium 99m pertechnetate salivary gland scintigraphy in patients with certain salivary gland diseases. J Oral Maxillofac Surg 73: 443-450. [Crossref]